USFDA completes Pre-Approval Inspection at Dr. Reddy’s Srikakulam formulations manufacturing facility

24 Aug 2024 Evaluate

The United States Food & Drug Administration (USFDA) has completed a product-specific Pre-Approval Inspection (PAI) at Dr. Reddy’s Laboratories’ formulations manufacturing facility (FTO SEZ PU1) in Srikakulam, Andhra Pradesh. The inspection was conducted from August 19, 2024 to August 23, 2024. The company has been issued a form 483 with three observations, which it will address within the stipulated timeline. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1268.60 -0.45 (-0.04%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×